Skip to content
Triangle logo TriangleGet started
← Melanoma

NCT01557881 · STUDY IN CONTEXT

Positron Emission Tomography/Magnetic Resonance Imaging in Patients

Draft scope assessment: narrower. Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.

Read the full study record and all posted results →

Linked outcomes

Measures are not ranked. Open each original source section for treatment groups, denominators, units and results.

primary · POSTED

SUVs for various normal tissues such as liver, cardiac blood pool, and bone will be used. Selected lesions will be assessed as well. Maximum and mean SUVs will be measured for each imaging device. The SUVs and tumor/background ratios will be measured.

Not available because SUV data not collected.

→

primary · POSTED

A Likert five point scale will be used. Quality scores will be compared using a Wilcoxon signed rank test.

Not available because data not collected.

→

primary · POSTED

A Likert five point scale will be used. Quality scores will be compared using a Wilcoxon signed rank test.

Not available because data not collected.

→

Reported safety

Serious events are not the same as severe events. Compare the original safety groups and their at-risk populations.

Open the study safety table →

Quality of life and patient-reported measures

No linked quality-of-life measure is recorded for this setting and study.

Full draft applicability and source-link record
trial
release id
clinical-indications-draft-1
disease state id
ds-melanoma
nct id
NCT01557881
trial label
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
applicability
narrower
applicability note
Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded.
curation status
draft
reviewed by
Source null
reviewed at
Source null
created at
2026-09-10T00:00:00Z
provenance class
registry-condition-search
discovery note
Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.
outcome Count
3
harms Count
1
qol Count
0
outcomes
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-melanoma
    nct id
    NCT01557881
    outcome key
    om-0000
    source section id
    NCT01557881-om-0000
    source outcome index
    0
    endpoint
    Standardized Uptake Value (SUV) on PET/CT Compared to PET/MRI
    endpoint definition
    SUVs for various normal tissues such as liver, cardiac blood pool, and bone will be used. Selected lesions will be assessed as well. Maximum and mean SUVs will be measured for each imaging device. The SUVs and tumor/background ratios will be measured.
    time origin
    After PET/MRI
    analysis role
    primary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Not available because SUV data not collected.
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  2. release id
    clinical-indications-draft-1
    disease state id
    ds-melanoma
    nct id
    NCT01557881
    outcome key
    om-0001
    source section id
    NCT01557881-om-0001
    source outcome index
    1
    endpoint
    Individual Quality Scores, Comprised of Various Qualities of the Image and Include Contrast, Brightness, Resolution, Etc.
    endpoint definition
    A Likert five point scale will be used. Quality scores will be compared using a Wilcoxon signed rank test.
    time origin
    After PET/MRI
    analysis role
    primary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Not available because data not collected.
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  3. release id
    clinical-indications-draft-1
    disease state id
    ds-melanoma
    nct id
    NCT01557881
    outcome key
    om-0002
    source section id
    NCT01557881-om-0002
    source outcome index
    2
    endpoint
    Comparison of Quality Scores (PET/CT vs PET/MRI), Comprised of Various Qualities of the Image and Include Contrast, Brightness, Resolution, Etc.
    endpoint definition
    A Likert five point scale will be used. Quality scores will be compared using a Wilcoxon signed rank test.
    time origin
    After PET/MRI
    analysis role
    primary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Not available because data not collected.
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
arms
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-melanoma
    nct id
    NCT01557881
    outcome key
    om-0000
    arm key
    OG000
    arm label
    Diagnostic (PET/MRI)
    regimen
    After undergoing standard PET/CT, patients undergo PET/MRI. magnetic resonance imaging with positron emission tomography scanning: University Hospitals Seidman Cancer Center \[SCC\] will house the Philips Ingenuity TF PET/MR, which is a hybrid scanner that merges magnetic resonance imaging with positron emission tomography scanning. University Hospitals is one of only five hospitals in the world with this technology. The PET/MRI system consists of two imaging scanners used sequentially as in PET/CT. The 3Tesla MRI component provides the high resolution that is necessary for soft tissue contrast and functional information on perfusion, diffusion, or metabolism. PET provides information about cellular metabolism and receptor status.
    analyzed count
    0
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT01557881-om-0000#groups/OG000
  2. release id
    clinical-indications-draft-1
    disease state id
    ds-melanoma
    nct id
    NCT01557881
    outcome key
    om-0001
    arm key
    OG000
    arm label
    Diagnostic (PET/MRI)
    regimen
    After undergoing standard PET/CT, patients undergo PET/MRI. magnetic resonance imaging with positron emission tomography scanning: University Hospitals Seidman Cancer Center \[SCC\] will house the Philips Ingenuity TF PET/MR, which is a hybrid scanner that merges magnetic resonance imaging with positron emission tomography scanning. University Hospitals is one of only five hospitals in the world with this technology. The PET/MRI system consists of two imaging scanners used sequentially as in PET/CT. The 3Tesla MRI component provides the high resolution that is necessary for soft tissue contrast and functional information on perfusion, diffusion, or metabolism. PET provides information about cellular metabolism and receptor status.
    analyzed count
    0
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT01557881-om-0001#groups/OG000
  3. release id
    clinical-indications-draft-1
    disease state id
    ds-melanoma
    nct id
    NCT01557881
    outcome key
    om-0002
    arm key
    OG000
    arm label
    Diagnostic (PET/MRI)
    regimen
    After undergoing standard PET/CT, patients undergo PET/MRI. magnetic resonance imaging with positron emission tomography scanning: University Hospitals Seidman Cancer Center \[SCC\] will house the Philips Ingenuity TF PET/MR, which is a hybrid scanner that merges magnetic resonance imaging with positron emission tomography scanning. University Hospitals is one of only five hospitals in the world with this technology. The PET/MRI system consists of two imaging scanners used sequentially as in PET/CT. The 3Tesla MRI component provides the high resolution that is necessary for soft tissue contrast and functional information on perfusion, diffusion, or metabolism. PET provides information about cellular metabolism and receptor status.
    analyzed count
    0
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT01557881-om-0002#groups/OG000
harms
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-melanoma
    nct id
    NCT01557881
    harm key
    EG000
    source section id
    NCT01557881-ae
    event group key
    EG000
    event group label
    Diagnostic (PET/MRI)
    serious affected
    0
    serious at risk
    98
    other affected
    0
    other at risk
    98
    frequency threshold
    5
    collection period
    At time of scan. No more than 24 hours.
    event definition
    No adverse events were documented for this study
    undenominated note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
quality of life
    setting source links

      Preserved source evidence · Not medical advice